Sponsor or institution
Clinical trials and research at Rapport Therapeutics Inc.
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Rapport Therapeutics Inc. that are recruiting, at sites in 4 countries (most in Australia (3), United States (3), South Korea (1)). 1 was first registered in the last 30 days. By phase: Phase 3 (2), Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1New in 30 days
- 4Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| RAP-219 long-acting injectable safety and PK study in healthy adults | Phase 1 | Adelaide | Recruiting | Nov 6, 2026 |
| RAP-219 for adults with focal seizures | Phase 3 | Huntsville, Alabama and 13 other locations | Recruiting | May 18, 2026 |
| RAP-219 in adults with focal seizures | Phase 3 | Birmingham, Alabama and 23 other locations | Recruiting | May 4, 2026 |
| Long-term RAP-219 treatment for adults with focal onset seizures | Phase 2 | Boise, Idaho and 6 other locations | Recruiting | Oct 21, 2025 |
All recruiting trials (4)
-
RAP-219 long-acting injectable safety and PK study in healthy adults
This early study tests RAP-219-LAI in healthy adults to see how it behaves in the body and whether it is safe and tolerable.
-
RAP-219 for adults with focal seizures
This study tests whether RAP-219 can reduce how often focal seizures happen in adults with focal epilepsy, compared with a placebo.
-
RAP-219 in adults with focal seizures
This study tests whether RAP-219 can safely reduce the number of focal seizures in adults with focal epilepsy compared with placebo.
-
Long-term RAP-219 treatment for adults with focal onset seizures
This trial will try RAP-219, an investigational anti-seizure medication, in adults with refractory focal seizures to see if it is safe long-term and helps reduce seizures.
Quick answers
How many clinical trials run by Rapport Therapeutics Inc. are recruiting right now?
4, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Australia (3 trials), United States (3 trials), South Korea (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.